公开(公告)号：EP1487484A2

公开(公告)日：2004-12-22

申请号：EP03727589.8

申请日：2003-03-14

申请人： INSTITUT PASTEUR DE LILLE ,  CENTRE NATIONAL DELA RECHERCHE SCIENTIFIQUE (CNRS) ,  UNIVERSITE DE LILLE II ,  INSTITUT NATIONAL DE LA SANTE ETDE LA RECHERCHE MEDICALE (INSERM) ,  SEDAC-Therapeutics (SOCIETE D'ETUDE ET DE DEVELOPPEMENT DES ANTIGENES COMBINATOIRES)

发明人： GUILLET, Jean-Gérard ,  BOURGAULT-VILLADA, Isabelle ,  DUPUIS, Marion ,  GRAS MASSE, Hélène ,  BOUREL, Line ,  MELNYK, Oleg ,  JOLY, Pascal ,  BONNET, Dominique ,  MALINGUE, Frédéric ,  GRAND JEAN, Cyrille ,  GEORGES, Bertrand

IPC分类号： A61K39/385 ,  A61K39/29 ,  A61K39/21 ,  C07K14/18 ,  A61P31/00 ,  A61P35/00

CPC分类号： C07K14/005 ,  A61K39/385 ,  A61K2039/542 ,  A61K2039/55555 ,  A61K2039/6018 ,  A61K2039/627 ,  C12N2740/15022 ,  C12N2740/16022 ,  C12N2770/24222

摘要： The invention relates to the use of a mixture containing at least lipopeptides for vaccine production. Said lipopeptides comprise a peptide compound which has been bound in solution by means of a hydrazone linkage to at least one non-peptidic lipophilic carrier. The invention also relates to native sequences NS3 of the HCV.